Ophthalmic plastic and reconstructive surgery۲۰۲۶مطالعه مشاهده اینمایه شده در PubMed
Rafaella C Penteado, Suzan Sargsyan, Leo L T Meller, Marissa K Shoji, Eman Al-Sharif, Don O Kikkawa, Bobby S Korn, Catherine Y Liu
چکیده
Teprotumumab, a monoclonal antibody targeting the insulin-like growth factor-1 receptor, has demonstrated significant efficacy in treating thyroid eye disease. While its ophthalmic benefits are well established, limited data exist regarding its effects on thyroid hormone regulation. To characterize…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1097/iop.0000000000003185